Placental growth factor testing in suspected pre-eclampsia

Michael Tanner; Ben W. Mol

doi:10.1016/S0140-6736(19)32496-1

Placental growth factor testing in suspected pre-eclampsia

Michael Tanner^* (Corresponding Author), Ben W. Mol

^*Corresponding author for this work

Monash University

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Abstract

We read with interest the Article by Kate Duhig and colleagues1 on the use of placental growth factor (PIGF) testing in patients with suspected pre-eclampsia. Although we appreciate the efforts of the authors, we are concerned that their results and interpretation are misleading.

Original language	English
Pages (from-to)	335
Number of pages	1
Journal	The Lancet
Volume	395
Issue number	10221
Early online date	30 Jan 2020
DOIs	https://doi.org/10.1016/S0140-6736(19)32496-1
Publication status	Published - 1 Feb 2020

Bibliographical note

BWM is supported by the National Health and Medical Research Council, and has received consulting fees from ObsEva, Merck, and Guerbet, research support from Merck, and travel support from Guerbet, outside of the submitted work. MT declares no competing interests.

Keywords

Female
Humans
Pre-Eclampsia
Pregnancy

Access to Document

10.1016/S0140-6736(19)32496-1Licence: Unspecified

Cite this

@article{85e3ce8931534611b040daf48d79dcfd,

title = "Placental growth factor testing in suspected pre-eclampsia",

abstract = "We read with interest the Article by Kate Duhig and colleagues1 on the use of placental growth factor (PIGF) testing in patients with suspected pre-eclampsia. Although we appreciate the efforts of the authors, we are concerned that their results and interpretation are misleading.",

keywords = "Female, Humans, Pre-Eclampsia, Pregnancy",

author = "Michael Tanner and Mol, {Ben W.}",

note = "BWM is supported by the National Health and Medical Research Council, and has received consulting fees from ObsEva, Merck, and Guerbet, research support from Merck, and travel support from Guerbet, outside of the submitted work. MT declares no competing interests. ",

year = "2020",

month = feb,

day = "1",

doi = "10.1016/S0140-6736(19)32496-1",

language = "English",

volume = "395",

pages = "335",

journal = "The Lancet",

issn = "0140-6736",

publisher = "ACADEMIC PRESS INC ELSEVIER SCIENCE",

number = "10221",

}

TY - JOUR

T1 - Placental growth factor testing in suspected pre-eclampsia

AU - Tanner, Michael

AU - Mol, Ben W.

N1 - BWM is supported by the National Health and Medical Research Council, and has received consulting fees from ObsEva, Merck, and Guerbet, research support from Merck, and travel support from Guerbet, outside of the submitted work. MT declares no competing interests.

PY - 2020/2/1

Y1 - 2020/2/1

N2 - We read with interest the Article by Kate Duhig and colleagues1 on the use of placental growth factor (PIGF) testing in patients with suspected pre-eclampsia. Although we appreciate the efforts of the authors, we are concerned that their results and interpretation are misleading.

AB - We read with interest the Article by Kate Duhig and colleagues1 on the use of placental growth factor (PIGF) testing in patients with suspected pre-eclampsia. Although we appreciate the efforts of the authors, we are concerned that their results and interpretation are misleading.

KW - Female

KW - Humans

KW - Pre-Eclampsia

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85078447466&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(19)32496-1

DO - 10.1016/S0140-6736(19)32496-1

M3 - Letter

C2 - 32007161

AN - SCOPUS:85078447466

SN - 0140-6736

VL - 395

SP - 335

JO - The Lancet

JF - The Lancet

IS - 10221

ER -

Placental growth factor testing in suspected pre-eclampsia

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this